1. A method for the treatment of a blood coagulation disorder in a patient in need thereof, comprising administering an effective amount of an activated form of FV variant or a derivative thereof thereby enhancing clot formation in said patient and ameliorating the symptoms of said blood coagulation disorder.
2. The method of claim 1, wherein said activated variant is encoded by a nucleic acid selected from the group consisting of SEQ ID NO:1 and SEQ ID NO: 2.
3. The method of claim 1, for the treatment of hemophilia A.
4. The method of claim 1, for the treatment of hemophilia B.
5. The method of claim 1, wherein said activated form of FV or derivative thereof is delivered intravenously or topically.
6. The method of claim 1, wherein a vector encoding the activated form of FV or derivative thereof is administered to said patient.
7. The method of claim 1, wherein said variant is a pro-coagulant and said disorder is selected from the group consisting of hemophilia A and B, hemophilia A and B associated with inhibitory antibodies, coagulation factor deficiency, vitamin K epoxide reductase C1 deficiency, gamma-carboxylase deficiency, bleeding associated with trauma, injury, thrombosis, thrombocytopenia, stroke, coagulopathy, disseminated intravascular coagulation (DIC); over-anticoagulation treatment disorders, Bernard Soulier syndrome, Glanzman thromblastemia, and storage pool deficiency.
8. The method of claim 7, wherein said over-anticoagulation treatment disorder results from administration of heparin, low molecular weight heparin, pentasaccharide, warfarin, small molecule antithrombotics and FXa inhibitors.
9. The method of claim 1, wherein said variant is administered intravenously at least once a day at a dosage between about 10 and 500 \u03bcgkg.
10. An isolated nucleic acid of SEQ ID NO: 2 encoding snake Factor V.
11. The nucleic acid of claim 10 contained in an expression vector.
12. An isolated host cell comprising the nucleic acid of claim 11.
13. An isolated snake Factor V protein encoded by the nucleic acid of SEQ ID NO: 1.
14. The protein of claim 13 contained in a liposome or micelle.
15. A pharmaceutical composition comprising the protein of claim 13 contained in a pharmaceutically acceptable excipient.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. An analysis system, comprising:
a processor configured to execute a program;
a memory configured to store the program,
the analysis system executing the program to analyze data,
the analysis system being capable of making access to a storage apparatus configured to store similarity information between data including a similarity between instances;
a data mapping unit configured to control the processor to set an attractive force and a repulsive force acting between the instances based on the similarity information between data, and arrange the instances in a vector space having a certain number of dimensions so that an energy caused by the attractive force and the repulsive force is less than a threshold defined in advance; and
a clustering unit configured to classify the instances arranged in the vector space,
wherein the data mapping unit is further configured to virtually add one dimension to the vector space, add a minute fluctuation to coordinates of the instances in a direction of the added dimension, and calculate a minimum number of dimensions of the vector space where the instances are stable with respect to the minute fluctuation.
2. An analysis system, comprising:
a processor configured to execute a program;
a memory configured to store the program,
the analysis system executing the program to analyze medical data,
the analysis system being capable of making access to a database configured to store medical information including an injury and illness name of a insured person and a medical action provided for the insured person, cost information on the medical action, and health checkup information including a test value acquired by a health checkup for the insured person;
a insured person arrangement coordinate generation unit configured to control the processor to calculate a similarity between insured persons based on the medical information and the health checkup information, and arrange the insured persons in a vector space having the same number of dimensions based on the calculated similarity;
a clustering unit configured to control the processor to classify the insured persons into clusters based on a coordinate at which each of the insured persons is arranged, and configure a pathologic transition model by using the classified clusters;
a pathologic transition probability calculation unit configured to control the processor to calculate a transition probability between the classified clusters;
a state characterizationreconfiguration unit configured to control the processor to reconfigure the pathologic transition model based on a cluster characterized by a specified item and a cluster determined by the characterized cluster and the transition probability;
a pathologic transitionmedical cost estimation unit configured to control the processor to estimate, based on the cost information on the medical action and based on one of the configured pathologic transition model or the reconfigured pathologic transition model, future state and medical cost of a disease; and
a health guidance support unit configured to control the processor to select, based on the estimated future state and the estimated medical cost of the disease, a person subject to a health guidance and a content of the health guidance,
wherein the insured person arrangement coordinate generation unit is further configured to:
arrange the insured persons in a vector space having a certain number of dimensions so that an energy caused by an attractive force and a repulsive force acting between the insured persons set based on the similarity is less than a threshold defined in advance;
virtually add one dimension to the vector space having the certain number of dimensions;
add a minute fluctuation to coordinates of the insured persons in a direction of the added dimension;
calculate a minimum number of dimensions of the vector space where the insured persons are stable with respect to the minute fluctuation; and
arrange the insured persons in a vector space having the calculated number of dimensions.
3. The analysis system according to claim 2, wherein the health guidance support unit is further configured to:
identify a cluster to which a insured person high in similarity to a insured person subject to analysis belongs as a current state of the insured person subject to analysis; and
calculate, based on a probability of transition from the identified cluster to another cluster, a probability that the insured person subject to analysis belongs to the another cluster.
4. The analysis system according to claim 2, wherein the health guidance support unit is further configured to:
replace the health checkup information on a insured person subject to analysis by an estimated value after reception of the health guidance, and then identify a cluster to which a insured person high in similarity to the insured person subject to analysis belongs; and
calculate, based on a probability of transition from the identified cluster to another cluster, a probability that the insured person subject to analysis belongs to the another cluster after the reception of the health guidance.
5. The analysis system according to claim 2, wherein the state characterizationreconfiguration unit is further configured to:
characterize the cluster by means of values acquired by statistically processing values of respective items of the insured person belonging to the cluster; and
generate, for an item having a statistically processed value large in separation from an average of insured persons, data for displaying the item characterizing the cluster and the statistically processed value.
6. The analysis system according to claim 2,
wherein the insured person arrangement coordinate generation unit is further configured to use an item acquired by unifying a plurality of items in the medical information to calculate the similarity between the insured persons.
7. The analysis system according to claim 2, further comprising a data formatting unit configured to control the processor to acquire a number of times of the medical action and a cost of the medical action from the medical information, to acquire the test value from the health checkup information, generate formatted information by summarizing the acquired information for each of the insured persons and for each predetermined period, and store the generated formatted information in the database,
wherein the insured person arrangement coordinate generation unit is further configured to calculate, for a certain item of the formatted information, the similarity between a first insured person and a second insured person by using a difference between a ratio of people having a value equal to or less than a value of the first insured person and a ratio of people having a value equal to or less than a value of the second insured person.
8. The analysis system according to claim 2, wherein the health guidance support unit is further configured to:
calculate an estimated effect by subtracting a second estimated medical cost acquired by replacing the test value of the insured person by a test value after the reception of the health guidance and a cost of the health guidance from the first estimated medical cost of the insured person; and
select a combination of a insured person high in the calculated estimated effect and the health guidance as the person subject to the health guidance and the content of the health guidance.
9. The analysis system according to claim 2, wherein the health guidance support unit is further configured to:
calculate a first risk of developing disease based on a ratio of a transition probability of a patholigical state of the insured person to an average transition probability of the pathological state;
calculate a second risk of developing disease by causing of an input of an improvement target value of the test value, and using a transition probability of the disease state acquired by replacing the test value of the insured person by the improvement target value; and
compare the first risk of developing disease and the second risk of developing disease with each other, to thereby generate data of a risk reduction effect through improvement.
10. The analysis system according to claim 9, wherein the analysis system is configured to configure a pathologic transition model for at least one of diabetes, hypertension, or dyslipidemia.
11. A health business support method for supporting a health guidance by using a computer including a processor for executing a program, and a memory for storing the program, the computer being capable of making access to a database for storing medical information including an injury and illness name of a insured person and a medical action provided for the insured person, cost information on the medical action, and health checkup information including a test value acquired by a health checkup for the insured person,
the health business support method including:
a insured person arrangement coordinate generation step of calculating, by the processor, a similarity between insured persons based on the medical information and the health checkup information, and arranging the insured persons in a vector space having the same number of dimensions based on the calculated similarity;
a clustering step of generating, by the processor, based on a coordinate at which each of the insured persons is arranged, a cluster into which the insured person is classified, and configuring a pathologic transition model by using generated clusters;
a state characterizationreconfiguration step of characterizing, by the processor, the cluster by means of a characteristic of the insured person belonging to the cluster, calculating, based on the medical information and the health checkup information, a transition probability between the generated clusters, and reconfiguring, based on the transition probability, a pathologic transition model configured by clusters characterized by a specified item;
a pathologic transitionmedical cost estimation step of estimating, by the processor, based on information including a cost of the medical action, and one of the configured pathologic transition model or the reconfigured pathologic transition model, future state and medical cost of a disease; and
a health guidance support step of selecting, by the processor, based on the estimated state and the estimated medical cost of the disease, a person subject to a health guidance and a content of the health guidance,
wherein the clustering step including steps of:
setting an attractive force and a repulsive force acting between the insured persons based on the similarity between the insured persons;
arranging the insured persons in a vector space having a certain number of dimensions so that an energy caused by the attractive force and the repulsive force is less than a threshold defined in advance;
virtually adding one dimension to the vector space having the certain number of dimensions;
adding a minute fluctuation to coordinates of the insured persons in a direction of the added dimension;
calculating a minimum number of dimensions of the vector space where the insured persons are stable with respect to the minute fluctuation; and
arranging the insured persons in a vector space having the calculated number of dimensions.